Natural History of Central Retinal Vein Occlusion: An Evidence-Based Systematic Review

Ophthalmology

Volumn 117, Issue 6, 2010, Pages

  McIntosh, Rachel L ^a   Rogers, Sophie L ^a   Lim, Lyndell ^a,b   Cheung, Ning ^a,b   Wang, Jie Jin ^a,c   Mitchell, Paul ^c   Kowalski, Jonathan W ^d   Nguyen, Hiep P ^d   Wong, Tien Yin ^a,b,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d ALLERGAN INC   (United States)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTRAL RETINA VEIN OCCLUSION; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE ASSOCIATION; DISEASE DURATION; HUMAN; LOW LEVEL LASER THERAPY; NEOVASCULAR GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA ISCHEMIA; RETINA MACULA EDEMA; SYSTEMATIC REVIEW; TREATMENT RESPONSE; VISUAL ACUITY; VITREOUS HEMORRHAGE;

EID: 77952890912     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2010.01.060     Document Type: Article

References (82)

1. Hayreh S. Prevalent misconceptions about acute retinal vascular occlusive disorders. Prog Retin Eye Res 24 (2005) 493-519
2. Klein R., Klein B.E., Moss S.E., and Meuer S.M. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 98 (2000) 133-141
3. Mitchell P., Smith W., and Chang A. Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study. Arch Ophthalmol 114 (1996) 1243-1247
4. Hayreh S., Zimmerman M., and Podhajsky P. Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics. Am J Ophthalmol 117 (1994) 429-441
5. CVOS group. Baseline and early natural history report: The Central Vein Occlusion Study. Arch Ophthalmol 111 (1993) 1087-1095
6. Hill D.W., and Griffiths J.D. The prognosis in retinal vein thrombosis. Trans Ophthalmol Soc UK 90 (1970) 309-322
7. Clemett R.S., Kohner E.M., and Hamilton A.M. The visual prognosis in retinal branch vein occlusion. Trans Ophthalmol Soc UK 93 (1973) 523-535
8. Chopdar A. Hemi-central retinal vein occlusion. Pathogenesis, clinical features, natural history and incidence of dual trunk central retinal vein. Trans Ophthalmol Soc U K 102 (1982) 241-248
9. Hayreh S.S., and Hayreh M.S. Hemi-central retinal vein occlusion. Pathogenesis, clinical features, and natural history. Arch Ophthalmol 98 (1980) 1600-1609
10. Jonas J.B., Kreissig I., and Degenring R.F. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graefe's Arch Clin Exp Ophthalmol 240 (2002) 782-783
11. Park C.H., Jaffe G.J., and Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 136 (2003) 419-425
12. Ramchandran R.S., Fekrat S., Stinnett S.S., and Jaffe G.J. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. Am J Ophthalmol 146 (2008) 285-291
13. National Institutes of Health. A randomized study comparing ranibizumab to sham in patients with macular edema secondary to CRVO. NCT00567697. ClinicalTrials.gov Accessed July 8, 2009
14. National Institutes of Health. The ROVO study: radial optic neurotomy for CVO. NCT00532142. ClinicalTrials.gov Accessed July 8, 2009
15. National Institutes of Health. A study of the efficacy and safety of Ranibizumab injection in patients with Macular Edema secondary to Central Retinal Vein Occlusion (CRUISE). NCT00485836 (2009). ClinicalTrials.gov Accessed April 23, 2009
16. Spandau U.H., Ihloff A.K., and Jonas J.B. Intravitreal bevacizumab treatment of macular oedema due to central retinal vein occlusion. Acta Ophthalmol Scand 84 (2006) 555-556
17. Rosenfeld P.J., Fung A.E., and Puliafito C.A. Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for macular edema from central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36 (2005) 336-339
18. Iturralde D., Spaide R.F., Meyerle C.B., et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 26 (2006) 279-284
19. Costa R.A., Jorge R., Calucci D., et al. Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO study. Retina 27 (2007) 141-149
20. Spaide R.F., Chang L.K., Klancnik J.M., et al. Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Am J Ophthalmol 147 (2008) 298-306
21. Mohamed Q., McIntosh R., Saw S., and Wong T. Interventions for central retinal vein occlusion: an evidence-based systematic review. Ophthalmology 114 (2006) 507-519 24
22. CVOS group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115 (1997) 486-491
23. Rogers S.L., McIntosh R.L., Lim L., et al. Natural history of branch retinal vein occlusion: an evidence-based systematic review. Ophthalmology 117 (2010) 1094-1101
24. Antcliff R.J., Mayer E.J., Williamson T.H., and Shilling J.S. Early chorioretinal anastomosis in non-ischaemic CRVO: a randomised trial [letter]. Br J Ophthalmol 89 (2005) 780-781
25. Braendstrup P. Central retinal vein thrombosis and hemorrhagic glaucoma. Acta Ophthalmol Suppl 35 (1950) 1-162
26. Cassady J.V. Central retinal vein thrombosis. Am J Ophthalmol 36 (1953) 331-335
27. Chan C.C., and Little H.L. Infrequency of retinal neovascularization following central retinal vein occlusion. Ophthalmology 86 (1979) 256-263
28. Chen J.C., Klein M.L., Watzke R.C., et al. Natural course of perfused central retinal vein occlusion. Can J Ophthalmol 30 (1995) 21-24
29. CVOS group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion: The Central Vein Occlusion Study Group N report. Ophthalmology 102 (1995) 1434-1444
30. CVOS group. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion: The Central Vein Occlusion Study Group M report. Ophthalmology 102 (1995) 1425-1433
31. D'Amato R.J., Miller N.R., Fine S.L., et al. The effect of age and initial visual acuity on the systemic and visual prognosis of central retinal vein occlusion. Aust N Z J Ophthalmol 19 (1991) 118-122
32. Fong A.C.O., Schatz H., McDonald H.R., et al. Central retinal vein occlusion in young adults (papillophlebitis). Retina 12 (1992) 3-11
33. Frucht J., Yanko L., and Merin S. Central retinal vein occlusions in young adults. Acta Ophthalmol 62 (1984) 780-786
34. Gelston C.D., Olson J.L., and Mandava N. Macular oedema in central retinal vein occlusion treated with intravitreal triamcinolone. Acta Ophthalmol Scand 84 (2006) 314-318
35. Giuffre G., Randazzo-Papa G., and Palumbo C. Central retinal vein occlusion in young people. Doc Ophthalmol 80 (1992) 127-132
36. Glacet-Bernard A., Coscas G., Chabanel A., et al. A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin. Am J Ophthalmol 118 (1994) 421-429
37. Glacet-Bernard A., Coscas G., Chabanel A., et al. Prognostic factors for retinal vein occlusion: a prospective study of 175 cases. Ophthalmology 103 (1996) 551-560
38. Gomez-Ulla de Irazazabal F.J., Suarez L.C., and Domingo E.O. Hemispheric retinal branch vein occlusions. Ophthalmologica 193 (1986) 14-22
39. Gomolin J.E.S. Efficacy of panretinal photocoagulation in central retinal vein occlusion. Ophthalmologica 199 (1989) 24-27
40. Gupta A., Agarwal A., Bansal R.K., and Chugh K.S. Ischaemic central retinal vein occlusion in the young. Eye 7 (1993) 138-142
41. Hansen L.L., Danisevskis P., Arntz H.R., et al. A randomised prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation. Br J Ophthalmol 69 (1985) 108-116
42. Hansen L.L., Wiek J., and Wiederholt M. A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol 73 (1989) 895-899
43. Hayreh S.S. So-called "central retinal vein occlusion". II. Venous stasis retinopathy. Ophthalmologica 172 (1976) 14-37
44. Hayreh S.S., Klugman M.R., Podhajsky P., et al. Argon laser panretinal photocoagulation in ischemic central retinal vein occlusion. A 10-year prospective study. Graefe's Arch Clin Exp Ophthalmol 228 (1990) 281-296
45. Hayreh S.S., Rojas P., and Podhajsky P. Ocular neovascularization with retinal vascular occlusion. III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology 90 (1983) 488-506
46. Hayreh S.S., Rubenstein L., and Podhajsky P. Argon laser scatter photocoagulation in treatment of branch retinal vein occlusion. A prospective clinical trial. Ophthalmologica 206 (1993) 1-14
47. Hvarfner C., and Larsson J. Is optic nerve head swelling of prognostic value in central retinal vein occlusion?. Graefe's Arch Clin Exp Ophthlamol 241 (2003) 463-467
48. Jonas J.B., Akkoyun I., Kamppeter B., et al. Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion. Eur J Ophthalmol 15 (2005) 751-758
49. Kohner E.M. Central retinal vein occlusion: natural history, associated medical conditions and treatment. Bull Soc Belge Ophtalmol 201 (1982) 1-13
50. Kohner E.M., Pettit J.E., Hamilton A.M., et al. Streptokinase in central retinal vein occlusion: a controlled clinical trial. Br Med J 1 (1976) 550-553
51. Laatikainen L., Kohner E.M., Khoury D., and Blach R.K. Panretinal photocoagulation in central retinal vein occlusion: a randomised controlled clinical study. Br J Ophthalmol 61 (1977) 741-753
52. Luckie A.P., Wroblewski J.J., Hamilton P., et al. A randomised prospective study of outpatient haemodilution for central retinal vein obstruction. Aust N Z J Ophthalmol 24 (1996) 223-232
53. Magargal L.E., Brown G.C., Augsburger J.J., and Parrish II R.K. Neovascular glaucoma following central retinal vein obstruction. Ophthalmology 88 (1981) 1095-1101
54. Magargal L.E., Donoso L.A., and Sanborn G.E. Retinal ischemia and risk of neovascularization following central retinal vein obstruction. Ophthalmology 89 (1982) 1241-1245
55. May D.R., Klein M.L., Peyman G.A., and Raichand M. Xenon arc panretinal photocoagulation for central retinal vein occlusion: a randomised prospective study. Br J Ophthalmol 63 (1979) 725-734
56. Minturn J., and Brown G.C. Progression of nonischemic central retinal vein obstruction to the ischemic variant. Ophthalmology 93 (1986) 1158-1162
57. Mirshahi A., Roohipoor R., Lashay A., et al. Surgical induction of chorioretinal venous anastomosis in ischaemic central retinal vein occlusion: a non-randomised controlled clinical trial. Br J Ophthalmol 89 (2005) 64-69
58. Moore R. Retinal vein thrombosis. Br J Ophthalmol 2 (1924) 4-90
59. Parodi M.B., Moretti G., and Ravalico G. Hemicentral and hemispheric retinal vein occlusions. Metab Pediatr Syst Ophthalmol 15 (1992) 64-67
60. Pollack A., Dottan S., and Oliver M. The fellow eye in retinal vein occlusive disease. Ophthalmology 96 (1989) 842-845
61. Pollack A., Leiba H., and Oliver M. Progression of nonischemic central retinal vein occlusion. Ophthalmologica 211 (1997) 13-20
62. Priluck I.A., Robertson D.M., and Hollenhorst R.W. Long-term follow-up of occlusion of the central retinal vein in young adults. Am J Ophthalmol 90 (1980) 190-202
63. Quinlan P.M., Elman M.J., Bhatt A.K., et al. The natural course of central retinal vein occlusion. Am J Ophthalmol 110 (1990) 118-123
64. Ramezani A., Entezari M., Moradian S., et al. Intravitreal triamcinolone for acute central retinal vein occlusion; a randomized clinical trial. Graefe's Arch Clin Exp Ophthlamol 244 (2006) 1601-1606
65. Recchia F.M., Carvalho-Recchia C.A., and Hassan T.S. Clinical course of younger patients with central retinal vein occlusion. Arch Ophthalmol 122 (2004) 317-321
66. Rubinstein K., and Jones E.B. Retinal vein occlusion: long-term prospects: 10 years' follow-up of 143 patients. Br J Ophthalmol 60 (1976) 148-150
67. Sinclair S.H., and Gragoudas E.S. Prognosis for rubeosis iridis following central retinal vein occlusion. Br J Ophthalmol 63 (1979) 735-743
68. Tewari H.K., Lemtor M.T., Azad R.V., and Verma L. Argon laser photocoagulation in acute central retinal vein occlusion. Afro-Asian J Ophthalmol 13 (1995) 88-91
69. Vannas S., and Raitta C. Anticoagulant treatment of retinal venous occlusion. Am J Ophthalmol 62 (1966) 874-884
70. Walters R.F., and Spalton D.J. Central retinal vein occlusion in people aged 40 years or less: a review of 17 patients. Br J Ophthalmol 74 (1990) 30-35
71. Weis E., Gan K.D., Hinz B.J., et al. A retrospective cohort study of radial optic neurotomy for severe central retinal vein occlusions. Can J Ophthlamol 43 (2008) 73-78
72. Wolf S., Arend O., Bertram B., et al. Hemodilution therapy in central retinal vein occlusion: one-year results of a prospective randomized study. Graefe's Arch Clin Exp Ophthlamol 232 (1994) 33-39
73. Zegarra H., Gutman F., and Conforto J. The natural course of central retinal vein occlusion. Ophthalmology 86 (1979) 1931-1942
74. Score Study Research Group. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion. Arch Ophthalmol 127 (2009) 1101-1114
75. Jadad A., Moore R., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 17 (1996) 1-12
76. Centre for Evidence Based Medicine. Centre for Evidence-Based Medicine levels of evidence (2001). http://www.cebm.downloads/Oxford_CEBM_Levels_5.rtf Accessed July 24, 2008
77. Holladay J. Visual acuity measurements. (editorial). J Cataract Refract Surg 30 (2004) 287-290
78. Reed G. Numerical Imputation for Low Vision States. IOVS electronic letters and authors response (2007). http://www.iovs.org/cgi/eletters/47/3/1236 Accessed November 26, 2007
79. Shilling J.S., and Jones C.A. Retinal branch vein occlusion: a study of argon laser photocoagulation in the treatment of macular oedema. Br J Ophthalmol 68 (1984) 196-198
80. Hayreh S. Management of central retinal vein occlusion. Ophthalmologica 217 (2003) 167-188
81. Klein R., Moss S.E., Meuer S.M., and Klein B.E. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol 126 (2008) 513-518
82. Cugati S., Wang J.J., Rochtchina E., and Mitchell P. Ten-year incidence of retinal vein occlusion in an older population: the Blue Mountains Eye Study. Arch Ophthalmol 124 (2006) 726-732